CD36 and hepatocellular carcinoma: In contrast, we found that the CD36 inhibitor SSO and SCD1 inhibitor A939572 abolished the anti-miR-3108-mediated enhancement in HCC cells (Fig. 6A–C; Additional file 1: Fig. S3A–C).